Zomedica Stock News

Zomedica (ZOM) stock is gaining on Monday following the release of its results for the full year of 2020 and approaching product launch. The post ZOM Stock: Why Zomedica Shares Are Zooming Higher Mond

On paper, the narrative for ZOM stock is exciting because of the relevant pet care business. However, you should analyze its true fundamentals very carefully.

ANN ARBOR, Mich., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products fo

In the meantime, the company still needs to execute the commercialization of Truforma. If it experiences any hiccups along the way, shares could fall back to lower price levels.

Long-term, ZOM stock has plenty to look forward to, including the release of its diagnostics platform. But that doesn't mean it's infallible.

Zomedica just raised approximately $200 million from a bought deal. Loaded with cash, ZOM stock look ready to move higher.

ZOM stock appears to be a trader's best friend right now, but is this stock truly a viable long-term investment opportunity? The post Zomedica Stock Has Soared 880% This Year — Here's Why appeared f

Will these high-flyers continue to soar?

Zomedica raised $173.5 million in a stock offering and saw ZOM stock take a hit as a result. But the stock price has almost fully rebounded.

Two popular stocks have made some investors rich over the past month.

With the market reading the popularity of ZOM stock as a negative, dip buyers can seize the window of opportunity while it exists. The post Uptrend Should Resume Soon for Zomedica Stock appeared first

It may be fun to dabble in meme stocks. But, don't consider it a surefire path to investing profits.

Zomedica (ZOM) may provide an update on Truforma commercialization progress when it reports fourth-quarter 2020 results.

While the pet care industry is a compelling one, ZOM stock occupies one of its riskiest subsegments, making the narrative insanely treacherous. The post Do You Love Your Pets That Much for Zomedica St

ANN ARBOR, Mich., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM), (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products